The High‐Mobility Group Box 1 Cytokine Induces Transporter‐Mediated Release of Glutamate from Glial Subcellular Particles (Gliosomes) Prepared from in Situ‐Matured Astrocytes

https://doi.org/10.1016/S0074-7742(07)82004-6Get rights and content

The multifunctional protein high‐mobility group box 1 (HMGB1) is expressed in restricted areas of adult brain where it can act as a proinflammatory cytokine. We report here that HMGB1 affects CNS transmission by inducing glutamatergic release from glial (gliosomes) but not neuronal (synaptosomes) resealed subcellular particles isolated from mouse cerebellum and hippocampus. Confocal microscopy showed that gliosomes are enriched with glia‐specific proteins such as GFAP and S‐100, but not with neuronal proteins such as PSD‐95, MAP‐2, and β‐tubulin III. Furthermore, gliosomes exhibit labeling neither for integrin‐αM nor for myelin basic protein, specific for microglia and oligodendrocytes, respectively. The gliosomal fraction contains proteins of the exocytotic machinery coexisting with GFAP. Consistent with ultrastructural analysis, several ∼30‐nm nonclustered vesicles are present in the gliosome cytoplasm. Finally, gliosomes represent functional organelles that actively export glutamate when subjected to releasing stimuli, such as ionomycin or ATP, by mechanisms involving extracellular Ca2+ and Ca2+ release from intracellular stores. HMGB1‐induced release of the stable glutamate analogue [3H]d‐aspartate and endogenous glutamate form gliosomes, whereas nerve terminals were insensitive to the protein. The HMGB1‐evoked release of glutamate was independent on modifications of cytosolic Ca2+ concentration, but it was blocked by dlthreo‐β‐benzyloxyaspartate, suggesting the involvement of transporter‐mediated release mechanisms. Moreover, dihydrokainic acid, a selective inhibitor of glutamate transporter 1 does not block the HMGB1 effect, indicating a role for the glial glutamate–aspartate transporter (GLAST) subtype in this response. HMGB1 bind to gliosomes but not to synaptosomes and can physically interact with GLAST and receptor for advanced glycation end products (RAGE). Taken together, these results suggest that the HMGB1 cytokine could act as a modulator of glutamate homeostasis in adult mammalian brain.

Introduction

In the last decade, exciting results have led to dramatic conceptual changes about the role of glial cells in the brain. For a long time, it was believed that glial cells provide structural, metabolic, and trophic support, while the task of information processing was attributed exclusively to neurons. An increasing number of papers suggest that glia shares at least some of the features typical of neurons, particularly those concerned with excitatory neurotransmission (reviewed in Haydon, 2001). In fact, glial cells are endowed with transporters able to remove glutamate from the extracellular space; a process even more efficient than that actuated by neurons (Bergles 1997, Mennerick 1994). Astrocytes, due to their intimate spatial relationship with neuronal synaptic contacts, can directly respond to synaptically released messengers and, in turn, communicate via signaling substances with neurons. The disclosure of this active role of glia has led to the model of the tripartite synapse (Araque et al., 1999), which affirms that a pivotal role in regulating synaptic function, strength, and plasticity is played by glial cells tightly surrounding pre‐ and postsynaptic neuronal elements.

Numerous stimuli have been reported to increase the intracellular Ca2+ concentration in astrocytes. As one of the foremost players, glutamate released from neurons can induce Ca2+ mobilization from intracellular stores by activating ionotropic and metabotropic receptors located on astroglial cells, which is associated with astrocytic glutamate release, through a process resembling neuronal exocytosis (reviewed in Montana et al., 2006). Interestingly, exocytotic‐like intracellular Ca2+‐driven glutamate release from astrocytes can also be elicited by substances involved in the inflammatory and immune pathways, including bradykinin (Parpura et al., 1994), prostaglandins (Bezzi et al., 1998), and chemokines (Bezzi et al., 2001).

A recently discovered member of the cytokine family is the high‐mobility group box 1 (HMGB1) protein that is widely expressed in developing nervous system and transformed cells of nerve origin, including neuroblastoma and glioma (Guazzi 2003, Sajithlal 2002, Taguchi 2000) and that can be actively exported by several cell types (Müller et al., 2004).

In this chapter, we summarize the results obtained studying the glutamate releasing properties of HMGB1, as well as the mechanisms underlining the extracellular export of the excitatory transmitter from astrocytes by exploiting the characteristics of gliosomes, a preparation of astrocyte subcellular particles acutely isolated from the brain of adult animals. This preparation appears well suited to investigate the functional neurochemistry of mature astrocytes. In particular, we show here that release of previously taken up [3H]d‐aspartate ([3H]d‐Asp) and of endogenous glutamate can be evoked from gliosomes by HMGB1 throughout reversal of the glial glutamate–aspartate transporter (GLAST).

Section snippets

Characterization of the Gliosome Preparation

Purified gliosomes and synaptosomes utilized in the experiments described here have been prepared from rat or mouse brain tissue by homogenization and purification on a discontinuous Percoll® gradient essentially according to Nakamura 1993, Nakamura 1994 with minor modifications (Stigliani et al., 2006). The tissue was homogenized in 14 volumes of 0.32‐M sucrose, buffered at pH 7.4 with Tris–HCl, using a glass–teflon tissue grinder (clearance 0.25 mm, 12 up–down strokes in about 1 min). The

Cytokine Properties of HMGB1

Cytokines are a class of small proteins acting via cell surface G‐protein–coupled receptors that mediate diverse metabolic and immunological responses in other cells (Nathan, 1987). They were first identified as inflammatory mediators of leukocyte chemotaxis and have been subsequently shown to possess a much larger repertoire (Rossi and Zlotnik, 2000). Various chemokines and their receptors are widely expressed in the brain, in some cases from early embryonic stages throughout adulthood (

Concluding Remarks

We reported here evidence that purified glial derived organelles isolated from the adult rat brain, referred as to gliosomes, are able to take up and release glutamate when subjected to a variety of stimuli. Data in the literature support the view that gliosomes may represent a viable preparation that allows the study of mechanisms of transmitter release and its regulation in adult astrocytes. Besides the obvious differences between gliosomes and intact cultured astrocytes, gliosomes may have a

Acknowledgments

This work was supported by the Italian Ministero dell'Istruzione, dell'Università e della Ricerca (PRIN 2002 and 2004), FIRB (Post‐Genoma and Neuroscience Projects), and University of Genoa. We thank Ms. Maura Agate for her excellent secretarial assistance.

References (57)

  • O. Hori et al.

    The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co‐expression of RAGE and amphoterin in the developing nervous system

    J. Biol. Chem.

    (1995)
  • G. Levi et al.

    Carrier‐mediated release of neurotransmitters

    Trends Neurosci.

    (1993)
  • R.J. Miller et al.

    AIDS and the brain: Is there a chemokine connection?

    Trends Neurosci.

    (1999)
  • Y. Moriyama et al.

    H(+)‐ATPase, a primary pump for accumulation of neurotransmitters, is a major constituent of brain synaptic vesicles

    Biochem. Biophys. Res. Commun.

    (1990)
  • K.A. O'Connor et al.

    Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: Central nervous system effects

    Cytokine

    (2003)
  • G. Sajithlal et al.

    Receptor for advanced glycation end products plays a more important role in cellular survival than in neurite outgrowth during retinoic acid‐induced differentiation of neuroblastoma cells

    J. Biol. Chem.

    (2002)
  • J.O. Thomas et al.

    HMG1 and 2, and related ‘architectural’ DNA‐binding proteins

    Trends Biochem. Sci.

    (2001)
  • M. Verhage et al.

    Differential release of amino acids, neuropeptides, and catecholamines from isolated nerve terminals

    Neuron

    (1991)
  • H. Wang et al.

    Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein‐1 by pituicytes

    Surgery

    (1999)
  • J.L. Arriza et al.

    Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex

    J. Neurosci.

    (1994)
  • P. Bezzi et al.

    Prostaglandins stimulate calcium‐dependent glutamate release in astrocytes

    Nature

    (1998)
  • P. Bezzi et al.

    CXCR4‐activated astrocyte glutamate release via TNFa: Amplification by microglia triggers neurotoxicity

    Nat. Neurosci.

    (2001)
  • E.J. Bowman et al.

    Bafilomycins: A class of inhibitors of membrane ATPase from microorganisms, animal cells and plant cells

    Biochemistry

    (1988)
  • M. Bustin

    Regulation of DNA‐dependent activities by the functional motifs of the high‐mobility‐group chromosomal proteins

    Mol. Cell. Biol.

    (1999)
  • K.K. Daniels et al.

    Reversible activation of glutamate transport in rat brain glia by protein kinase C and an okadaic acid‐sensitive phosphoprotein phosphatase

    Neurochem. Res.

    (1999)
  • J. Dunlop et al.

    Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis

    J. Neurosci.

    (2003)
  • C. Fages et al.

    Regulation of cell migration by amphoterin

    J. Cell Sci.

    (2000)
  • E. Floor et al.

    Partial purification and characterization of the vacuolar H+‐ATPase of mammalian synaptic vesicles

    J. Neurochem.

    (1990)
  • Cited by (15)

    • RAGE Signaling pathway in hippocampus dentate gyrus involved in GLT-1 decrease induced by chronic unpredictable stress in rats

      2020, Brain Research Bulletin
      Citation Excerpt :

      HMGB1 was found involved in NMDA-induced retinal injury at least in part by activation of RAGE in rats (Sakamoto et al., 2015). HMGB1 could modulate glutamate release from gliosomes by interacting with glutamate transporters and RAGE (Bonanno et al., 2007). The promoter of GLT-1 gene has the binding sites for p-CREB and p-p65 (Karki et al., 2013, 2014) which are known as downstream molecules of RAGE signaling pathway.

    • Inflammation and reactive oxygen species as disease modifiers in epilepsy

      2020, Neuropharmacology
      Citation Excerpt :

      TNF induces endocytosis of GABAA receptors and reduces the inhibitory synaptic strength by activating TNFR1 (Stellwagen et al., 2005). IL-1β, HMGB1 and TNF affect neuronal excitability also by increasing the extracellular glutamate concentration by inhibiting the astroglial glutamate transporter (Bonanno et al., 2007; Hu et al., 2000; Zou and Crews, 2005). HMGB1 and TNF enhance gliotransmission by inducing glutamate release from hippocampal gliosomes (Pedrazzi et al., 2006) and from activated astrocytes (Bezzi et al., 2001) and microglia (Takeuchi et al., 2006) cultures, respectively.

    • HMGB1 in health and disease

      2014, Molecular Aspects of Medicine
      Citation Excerpt :

      The vagus nerve can modulate systemic inflammation and HMGB1 release through the alpha7 nicotinic acetylcholine receptor (alpha7nAchR), suggesting a potential role of neurotransmitters in the regulation of HMGB1 release. In contrast, extracellular HMGB1 also has the ability to stimulate the release of glutamate and its analogues from gliosomes by binding to RAGE and glial glutamate–aspartate transporter (GLAST), suggesting a critical role of HMGB1 in the regulation of glutamate homeostasis in the brain (Bonanno et al., 2007). Macrophages differentiate from circulating PBMCs, common progenitor cells for many cell types such as dendritic cells and mast cells.

    • Targeting HMGB1 in inflammation

      2010, Biochimica et Biophysica Acta - Gene Regulatory Mechanisms
    • The role of HMGB-1 and its inhibitors in brain disorders

      2022, HMGB1: Functions, Inhibitors and Clinical Significance
    View all citing articles on Scopus
    View full text